Hetero-benzazepine derivatives and their pharmaceutical use

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Allergen or component thereof

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424244, 424263, 2602393B, 2602393T, A61K 3155, C07D51304

Patent

active

044774648

ABSTRACT:
Disclosed are variously substituted 3-(carboxymethylamino)-(1,5-benzothiazepin-4-one, 1,5-benzoxazepin-4-one and 1,5-benzodiazepin-4-one)-5-alkanoic acids and derivatives as angiotensin-converting enzyme inhibitors and antihypertensive agents. Their synthesis, pharmaceutical compositions thereof, and methods of threatment utilizing such compounds are included.

REFERENCES:
patent: 3661927 (1972-05-01), Zimkovic
patent: 3748321 (1973-07-01), Krapcho
patent: 4410520 (1983-10-01), Watthey
patent: 4416819 (1983-11-01), Nagao et al.
Levai A., Acta Chimica Academie Scientiariam Hungaricae, vol. 102, pp. 141-142, (1979).
Levai A., Pharmazie, vol. 35, pp. 680-681, (1980).
Ito, S., Bull. Chem. Soc. Jap., vol. 43, p. 1824, (1970), Chem Abstr. vol. 92, item 22531a.
Evans et al., J. Chem. Soc., (1965), pp. 4806-4812.
G. S. Sidhu et al., J. Chem. Soc., (1966), pp. 969-971.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Hetero-benzazepine derivatives and their pharmaceutical use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hetero-benzazepine derivatives and their pharmaceutical use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hetero-benzazepine derivatives and their pharmaceutical use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1945167

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.